ZEN and the art of breast health maintenance

International Journal of Clinical Practice

Volumn 66, Issue 1, 2012, Pages 28-36

  Pazaiti, A ^a   Kontos, M ^a   Fentiman, I S ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA ZEARALENOL; ANTIOXIDANT; ESTRADIOL; OPUNTIA FICUS EXTRACT; PLANT EXTRACT; PROTEIN DISULFIDE ISOMERASE; RALOXIFENE; UNCLASSIFIED DRUG; ZEARALENONE;

ATHEROSCLEROTIC PLAQUE; BREAST CANCER; BREAST CARCINOGENESIS; DETOXIFICATION; DRUG MECHANISM; DRUG STRUCTURE; ESTROGEN ACTIVITY; HEALTH HAZARD; HORMONE SUBSTITUTION; HUMAN; LIVER TOXICITY; MYCOTOXICOSIS; NEPHROTOXICITY; NONHUMAN; OPUNTIA; OPUNTIA FICUS; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; REVIEW; XENOBIOTIC METABOLISM;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CATTLE; CELL LINE, TUMOR; DIET; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS, NON-STEROIDAL; FEMALE; FOOD CONTAMINATION; GROWTH SUBSTANCES; HORMONE REPLACEMENT THERAPY; HUMANS; METABOLIC DETOXICATION, DRUG; PUBERTY, PRECOCIOUS; RECEPTORS, ESTROGEN; ZEARALENONE; ZERANOL;

EID: 83955162178     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02805.x     Document Type: Review

References (91)

1. Li JJ, Li SA,. Natural and anthropogenic environmental oestrogens: the scientific basis for risk assessment. Breast cancer: evidence for xeno-estrogen involvement in altering its incidence and risk. Pure Appl Chem 1998; 70: 1713-23.
2. Kuiper-Goodman T, Scott PM, Watanabe H,. Risk assessment of the mycotoxin zearalenone. Regul Toxicol Pharmacol 1987; 7: 253-306.
3. JECFA 2000. Joint FAO/WHO Expert Committee on Food Additives, 53rd Report. Safety evaluation of certain food additives. WHO Food Additives Series 44. Rome: World Health Organisation.
4. Chang K, Kurtz HJ, Mirocha CJ,. Effects of the mycotoxin zearalenone on swine reproduction. Am J Vet Res 1979; 40: 1260-7. (Pubitemid 10116598)
5. Etienne M, Jemmali M,. Effects of zearalenone (F2) on estrous activity and reproduction in gilts. J Anim Sci 1982; 55: 1-10.
6. Massart F, Meucci V, Saggese G, Soldani G,. High growth rate of girls with precocious puberty exposed to estrogenic mycotoxins. J Pediatr 2008; 152: 690-5. 5 e1
7. Fara GM, Del Corvo G, Bernuzzi S, et al., Epidemic of breast enlargement in an Italian school. Lancet 1979; 2: 295-7. (Pubitemid 9244109)
8. Krstevska-Konstantinova M, Charlier C, Craen M, et al., Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides. Hum Reprod 2001; 16: 1020-6. (Pubitemid 32451843)
9. Szuetz P, Mesterhazy A, Falkay GY, Bartok T,. Early telarche symptoms in children and their relations to zearalenone contamination in foodstuffs. Cereals Res Com 1997; 25: 429-36. (Pubitemid 27492980)
10. Tomaszewski J, Miturski R, Semczuk A, Kotarski J, Jakowicki J,. Tissue zearalenone concentration in normal, hyperplastic and neoplastic human endometrium. Ginekol Pol 1998; 69: 363-6.
11. Khosrokhavar R, Rahimifard N, Shoeibi S, Hamedani MP, Hosseini MJ,. Effects of zearalenone and alphα-ZEA ralenol in comparison with raloxifene on T47D cells. Toxicol Mech Methods 2009; 19: 246-50.
12. Makela S, Davis VL, Tally WC, et al., Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 1994; 102: 572-8. (Pubitemid 24241281)
13. Martin PM, Horwitz KB, Ryan DS, McGuire WL,. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978; 103: 1860-7. (Pubitemid 9052644)
14. Zava DT, Blen M, Duwe G,. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect 1997; 105 (Suppl 3): 637-45. (Pubitemid 27246429)
15. Dees C, Foster JS, Ahamed S, Wimalasena J,. Dietary estrogens stimulate human breast cells to enter the cell cycle. Environ Health Perspect 1997; 105 (Suppl 3): 633-6. (Pubitemid 27246428)
16. Withanage GS, Murata H, Koyama T, Ishiwata I,. Agonistic and antagonistic effects of zearalenone, an etrogenic mycotoxin, on SKN, HHUA, and HepG2 human cancer cell lines. Vet Hum Toxicol 2001; 43: 6-10. (Pubitemid 32112892)
17. Yuri T, Tsukamoto R, Miki K, Uehara N, Matsuoka Y, Tsubura A,. Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells. Oncol Rep 2006; 16: 1307-12.
18. NTP. Carcinogenicity bioassay of zearalenone in F344/N rats and F6C3F1 mice. National Toxicology Program Technical Reports Series 235. National Toxicology Program. NC: Research Triangle Park, 1982.
19. Maaroufi K, Chekir L, Creppy EE, Ellouz F, Bacha H,. Zearalenone induces modifications of haematological and biochemical parameters in rats. Toxicon 1996; 34: 535-40. (Pubitemid 26164342)
20. Berek L, Petri IB, Mesterhazy A, Teren J, Molnar J,. Effects of mycotoxins on human immune functions in vitro. Toxicol In Vitro 2001; 15: 25-30. (Pubitemid 32226371)
21. Pfohl-Leszkowicz A, Chekir-Ghedira L, Bacha H,. Genotoxicity of zearalenone, an estrogenic mycotoxin: DNA adduct formation in female mouse tissues. Carcinogenesis 1995; 16: 2315-20.
22. Abid-Essefi S, Baudrimont I, Hassen W, et al., DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK, Vero and Caco-2 cells: prevention by vitamin E. Toxicology 2003; 192: 237-48. (Pubitemid 37311414)
23. Lioi MB, Santoro A, Barbieri R, Salzano S, Ursini MV,. Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutat Res 2004; 557: 19-27. (Pubitemid 38045578)
24. Liu S, Lin YC,. Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta. Breast J 2004; 10: 514-21. (Pubitemid 39524985)
25. Council for Agricultural Science and Technology. Mycotoxins. Economic and Health Risks. Council for Agricultural Science and Technology Task Force Report. No. 116. Ames, IA: Council for Agricultural Science and Technology, 1989.
26. Hodge EG., Hidy PH., Wehrmeister HJ,. Estrogenic compounds and animal growth promoters. U.S. Patent 3239345 1966.
27. Hidy PH, Baldwin RS, Greasham RL, Keith CL, McMullen JR,. Zearalenone and some derivatives: production and biological activities. Adv Appl Microbiol 1977; 22: 59-82.
28. Bennett JW, Klich M,. Mycotoxins. Clin Microbiol Rev. 2003; 16: 497-516. (Pubitemid 36871318)
29. Hagler WM, Towers JNR., Mirocha CJ, Eppley RM, Bryden WL, eds. Zearalenone: Mycotoxin or Mycoestrogen? St. Paul, MN: APS Press, 2001.
30. Urry WH, Wehrmeister HL, Hodge EB, H. HP,. The structure of zearalenone. Tetrahedron Lett 1966; 27: 3109-14.
31. Mirocha CJ, Christensen CM, Nelson GH,. Estrogenic metabolite produced by Fusarium graminearum in stored corn. Appl Microbiol 1967; 15: 497-503.
32. Zinedine A, Soriano JM, Molto JC, Manes J,. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem Toxicol 2007; 45: 1-18. (Pubitemid 44792326)
33. CCFAC. Codex Committee on Food Additives and Contaminants. Posting date. Joint FAO/WHO Expert Committee on Food Additives: Position paper on zearalenone. Publication CCFAC 00/19. Rome, Italy: Codex Alimentarius Commission, 2000.
34. Pineiro M, Dawson R, Costarrica ML,. Monitoring program for mycotoxin contamination in Uruguayan food and feeds. Nat Toxins 1996; 4: 242-5. (Pubitemid 26411546)
35. Lombaert GA, Pellaers P, Roscoe V, Mankotia M, Neil R, Scott PM,. Mycotoxins in infant cereal foods from the Canadian retail market. Food Addit Contam 2003; 20: 494-504. (Pubitemid 36798890)
36. Schoental R,. Precocious sexual development in Puerto Rico and oestrogenic mycotoxins (zearalenone). Lancet 1983; 1: 537. (Pubitemid 13195515)
37. Massart F, Seppia P, Pardi D, et al., High incidence of central precocious puberty in a bounded geographic area of northwest Tuscany: an estrogen disrupter epidemic? Gynecol Endocrinol 2005; 20: 92-8. (Pubitemid 40604024)
38. Minervini F, Giannoccaro A, Cavallini A, Visconti A,. Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicol Lett 2005; 159: 272-83. (Pubitemid 41501592)
39. Olsen M, Malmlof K, Pettersson H, Sandholm K, Kiessling KH,. Plasma and urinary levels of zearalenone and alphα-ZEA ralenol in a prepubertal gilt fed zearalenone. Acta Pharmacol Toxicol (Copenh) 1985; 56: 239-43. (Pubitemid 15149191)
40. Biehl ML, Prelusky DB, Koritz GD, Hartin KE, Buck WB, Trenholm HL,. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicol Appl Pharmacol 1993; 121: 152-9. (Pubitemid 23221285)
41. Tiemann U, Viergutz T, Jonas L, Schneider F,. Influence of the mycotoxins alpha- and betα-ZEA ralenol and deoxynivalenol on the cell cycle of cultured porcine endometrial cells. Reprod Toxicol 2003; 17: 209-18. (Pubitemid 36428315)
42. Shier WT, Shier AC, Xie W, Mirocha CJ,. Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon 2001; 39: 1435-8. (Pubitemid 32510976)
43. Leffers H, Naesby M, Vendelbo B, Skakkebaek NE, Jorgensen M,. Oestrogenic potencies of zeranol, oestradiol, diethylstilboestrol, bisphenol-A and genistein: implications for exposure assessment of potential endocrine disrupters. Hum Reprod 2001; 16: 1037-45. (Pubitemid 32451846)
44. Takemura H, Shim JY, Sayama K, Tsubura A, Zhu BT, Shimoi K,. Characterization of the estrogenic activities of zearalenone and zeranol in vivo and in vitro. J Steroid Biochem Mol Biol 2007; 103: 170-7. (Pubitemid 46149301)
45. Hilakivi-Clarke L, Onojafe I, Raygada M, et al., Prepubertal exposure to zearalenone or genistein reduces mammary tumourigenesis. Br J Cancer 1999; 80: 1682-8. (Pubitemid 29389619)
46. Dai S, Duan J, Lu Y, et al., Alphα-ZEA ralanol, a phytoestrogen for cardiovascular therapy. Endocrine 2004; 25: 117-9. (Pubitemid 41271137)
47. Yuri T, Nikaido Y, Shimano N, Uehara N, Shikata N, Tsubura A,. Effects of prepubertal zeranol exposure on estrogen target organs and N-methyl-N- nitrosourea-induced mammary tumourigenesis in female Sprague-Dawley rats. In Vivo 2004; 18: 755-61.
48. Nikaido Y, Danbara N, Tsujita-Kyutoku M, Yuri T, Uehara N, Tsubura A,. Effects of prepubertal exposure to xenoestrogen on development of estrogen target organs in female CD-1 mice. In Vivo 2005; 19: 487-94. (Pubitemid 40568125)
49. Baldwin RS, Williams RD, Terry MK,. Zeranol: a review of the metabolism, toxicology, and analytical methods for detection of tissue residues. Regul Toxicol Pharmacol 1983; 3: 9-25. (Pubitemid 13095119)
50. Apple JK, Dikeman ME, Simms DD, Kuhl G,. Effects of synthetic hormone implants, singularly or in combinations, on performance, carcass traits, and longissimus muscle palatability of Holstein steers. J Anim Sci 1991; 69: 4437-48.
51. Lemieux PG, Byers FM, Schelling GT,. Relationship of anabolic status and phase and rate of growth to priorities for protein and fat deposition in steers. J Anim Sci 1990; 68: 1702-10.
52. Moran C, Prendiville DJ, Quirke JF, Roche JF,. Effects of oestradiol, zeranol or trenbolone acetate implants on puberty, reproduction and fertility in heifers. J Reprod Fertil 1990; 89: 527-36. (Pubitemid 20238667)
53. Williams JE, Ireland SJ, Mollett TA, Hancock DL, Beaver EE, Hannah S,. Influence of zeranol and breed on growth, composition of gain, and plasma hormone concentrations. J Anim Sci 1991; 69: 1688-96.
54. Lindsay DG,. Zeranol-a 'nature-identical' oestrogen? Food Chem Toxicol 1985; 23: 767-74.
55. Fugh-Berman A,. 'Bust enhancing' herbal products. Obstet Gynecol 2003; 101: 1345-9.
56. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP,. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003; 24: 668-93. (Pubitemid 37330586)
57. Pillay D, Chuturgoon AA, Nevines E, Manickum T, Deppe W, Dutton MF,. The quantitative analysis of zearalenone and its derivatives in plasma of patients with breast and cervical cancer. Clin Chem Lab Med 2002; 40: 946-51. (Pubitemid 35277423)
58. Juniewicz PE, Welsh TH Jr, Johnson BH,. Effects of zeranol upon bovine testicular function. Theriogenology 1985; 23: 565-82.
59. Saenz de Rodriguez CA, Bongiovanni AM, Conde de Borrego L,. An epidemic of precocious development in Puerto Rican children. J Pediatr 1985; 107: 393-6. (Pubitemid 15240794)
60. Saenz de Rodriguez CA,. Environmental hormone contamination in Puerto Rico. N Engl J Med 1984; 310: 1741-2. (Pubitemid 14124600)
61. Lampit M, Golander A, Guttmann H, Hochberg Z,. Estrogen mini-dose replacement during GnRH agonist therapy in central precocious puberty: a pilot study. J Clin Endocrinol Metab 2002; 87: 687-90. (Pubitemid 34158238)
62. Key TJ, Verkasalo PK, Banks E,. Epidemiology of breast cancer. Lancet Oncol 2001; 2: 133-40. (Pubitemid 33585924)
63. Clarke R, Hilakivi-Clarke L, Trock B,. Breast cancer: dietary and environmental oestrogens. Biologist (London) 2001; 48: 21-6. (Pubitemid 32183927)
64. Barnes S,. Phytoestrogens and breast cancer. Baillieres Clin Endocrinol Metab 1998; 12: 559-79. (Pubitemid 29261271)
65. Safe SH,. Is there an association between exposure to environmental estrogens and breast cancer? Environ Health Perspect 1997; 105: 675-8. (Pubitemid 27246433)
66. Schoental R,. Letter: role of podophyllotoxin in the bedding and dietary zearalenone on incidence of spontaneous tumours in laboratory animals. Cancer Res 1974; 34: 2419-20.
67. Ahamed S, Foster JS, Bukovsky A, Wimalasena J,. Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells. Mol Carcinog 2001; 30: 88-98.
68. Parveen M, Zhu Y, Kiyama R,. Expression profiling of the genes responding to zearalenone and its analogues using estrogen-responsive genes. FEBS Lett 2009; 583: 2377-84.
69. Ramanathan L, Gray WG,. Identification and characterization of a phytoestrogen-specific gene from the MCF-7 human breast cancer cell. Toxicol Appl Pharmacol 2003; 191: 107-17. (Pubitemid 36999847)
70. Yu Z, Zhang L, Wu D, Liu F,. Anti-apoptotic action of zearalenone in MCF-7 cells. Ecotoxicol Environ Saf 2005; 62: 441-6. (Pubitemid 41427148)
71. Yu Z, Hu D, Li Y,. Effects of zearalenone on mRNA expression and activity of cytochrome P450 1A1 and 1B1 in MCF-7 cells. Ecotoxicol Environ Saf 2004; 58: 187-93. (Pubitemid 38638534)
72. Subbiah MT,. Estrogen replacement therapy and cardioprotection: mechanisms and controversies. Braz J Med Biol Res 2002; 35: 271-6. (Pubitemid 34285499)
73. Mosca L, Collins P, Herrington DM, et al., Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 499-503. (Pubitemid 32678285)
74. Dai S, Duan J, Lu Y, et al., Phytoestrogen alphα-ZEA ralanol inhibits atherogenesis and improves lipid profile in ovariectomized cholesterol-fed rabbits. Endocrine 2004; 25: 121-9. (Pubitemid 41271138)
75. Altavilla D, Saitta A, Galeano M, et al., The phytoestrogen alphα-ZEA ralenol reverses endothelial dysfunction induced by oophorectomy in rats. Lab Invest 2001; 81: 125-32. (Pubitemid 32176375)
76. el-Sharkawy S, Abul-Hajj YJ,. Microbial cleavage of zearalenone. Xenobiotica 1988; 18: 365-71.
77. Takahashi-Ando N, Kimura M, Kakeya H, Osada H, Yamaguchi I,. A novel lactonohydrolase responsible for the detoxification of zearalenone: enzyme purification and gene cloning. Biochem J 2002; 365: 1-6. (Pubitemid 34756133)
78. Updike MS, Sawdy JC, Wang LS, et al., Primary cultured human breast epithelial cells up-regulate protein disulfide isomerase in response to zeranol. Anticancer Res 2007; 27: 407-10. (Pubitemid 46363360)
79. Barrett-Connor E,. Raloxifene: risks and benefits. Ann N Y Acad Sci 2001; 949: 295-303. (Pubitemid 34061908)
80. Kim HT, Kim BC, Kim IY, et al., Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells. J Biol Chem 2002; 277: 32510-5. (Pubitemid 34984754)
81. Hassen W, Ayed-Boussema I, Oscoz AA, Lopez Ade C, Bacha H,. The role of oxidative stress in zearalenone-mediated toxicity in Hep G2 cells: oxidative DNA damage, gluthatione depletion and stress proteins induction. Toxicology 2007; 232: 294-302. (Pubitemid 46454347)
82. Feugang JM, Konarski P, Zou D, Stintzing FC, Zou C,. Nutritional and medicinal use of Cactus pear (Opuntia spp.) cladodes and fruits. Front Biosci 2006; 11: 2574-89. (Pubitemid 43806566)
83. Zourgui L, Golli EE, Bouaziz C, Bacha H, Hassen W,. Cactus (Opuntia ficus-indica) cladodes prevent oxidative damage induced by the mycotoxin zearalenone in Balb/C mice. Food Chem Toxicol 2008; 46: 1817-24.
84. Kuti JO,. Antioxidant compounds from four Opuntia cactus pear fruit varieties. Food Chem Toxicol 2004; 85: 527-33. (Pubitemid 38142498)
85. Park EH, Kahng JH, Paek EA,. Studies on the pharmacological action of cactus: identification of its anti-inflammatory effect. Arch Pharm Res 1998; 21: 30-4.
86. Tesoriere L, Fazzari M, Allegra M, Livrea MA,. Biothiols, taurine, and lipid-soluble antioxidants in the edible pulp of Sicilian cactus pear (Opuntia ficus-indica) fruits and changes of bioactive juice components upon industrial processing. J Agric Food Chem 2005; 53: 7851-5. (Pubitemid 41499630)
87. Shim HC, Hwang HJ, Kang KJ, Lee BH,. An antioxidative and anti-inflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch Pharm Res 2006; 29: 165-71. (Pubitemid 43352466)
88. Nam SY, Cho CK, Kim SG,. Correlation of increased mortality with the suppression of radiation-inducible microsomal epoxide hydrolase and glutathione S-transferase gene expression by dexamethasone: effects on vitamin C and E-induced radioprotection. Biochem Pharmacol 1998; 56: 1295-304. (Pubitemid 28512677)
89. Yilmaz S, Yilmaz E,. Effects of melatonin and vitamin E on oxidative-antioxidative status in rats exposed to irradiation. Toxicology 2006; 222: 1-7.
90. Grosse Y, Chekir-Ghedira L, Huc A, et al., Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone. Cancer Lett 1997; 114: 225-9. (Pubitemid 27140119)
91. Ghedira-Chekir L, Maaroufi K, Zakhama A, et al., Induction of a SOS repair system in lysogenic bacteria by zearalenone and its prevention by vitamin E. Chem Biol Interact 1998; 113: 15-25. (Pubitemid 28279788)